Takuro Sato

Yahaba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injury.

Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injury.

Journal: Molecular genetics and metabolism

Published: January 10, 2025

Over 3-Years Follow-Up of a Case of Primary Biliary Cholangitis With Autoimmune Hyperthyroidism: Factors Associated With Liver Dysfunction.

Over 3-Years Follow-Up of a Case of Primary Biliary Cholangitis With Autoimmune Hyperthyroidism: Factors Associated With Liver Dysfunction.

Journal: Cureus

Published: December 25, 2022

Lactulose: A treatment for hyperammonemia in a lysinuric protein-intolerant patient with dynamic blood amino acid concentrations.

Lactulose: A treatment for hyperammonemia in a lysinuric protein-intolerant patient with dynamic blood amino acid concentrations.

Journal: Molecular genetics and metabolism reports

Published: June 06, 2022

Viral eradication by direct-acting antivirals does not decrease the serum myostatin level in patients infected with hepatitis C virus.

Viral eradication by direct-acting antivirals does not decrease the serum myostatin level in patients infected with hepatitis C virus.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: November 09, 2021

Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury.

Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury.

Journal: Scientific reports

Published: August 14, 2020

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.

Journal: Cancers

Published: June 26, 2020

Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease.

Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 19, 2020

Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection.

Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection.

Journal: Journal of gastroenterology and hepatology

Published: June 22, 2019

Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.

Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.

Journal: Internal medicine (Tokyo, Japan)

Published: January 11, 2019

A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients.

A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 18, 2018

Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug-induced liver injury by direct acting antivirals.

Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug-induced liver injury by direct acting antivirals.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 31, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026